Bioharmony Therapeutics, Inc. Company Profile
News Articles
Technical Perspectives on Biotech Stocks -- Adaptimmune Therapeutics, Akebia Therapeutics, ...
www.wallstequities.com/registration Adaptimmune Therapeutics Shares in Abingdon, the UK headquartered Adaptimmune Therapeutics PLC rose slightly by 0.41%, ending Wednesday's trading session at $12...
M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin
Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...
Q Therapeutics, ReproCELL form MAGiQ, a CNS diseases JV
Fellow cell therapy companies Q Therapeutics Inc. and ReproCELL Inc. formed a 50/50-owned CNS disease-focused joint venture, which will be headquartered in Japan and known as MAGiQ Therapeutics Inc. R...
HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics
The acquisition strengthens HiFiBiO Therapeutics’ strategic focus on identifying first-in-class targets for multiple immune cell types, as well as applying industry-leading technologies to develop d...
Aquinox Pharmaceuticals, Summit Therapeutics and Global Blood Therapeutics are also making news
Deals and M&As this week: Pliant Therapeutics, MolMed, Modus Therapeutics
Pliant Therapeutics has raised $62m through a series B financing round from Cowen Healthcare Investments. The funding round also included participation...Read More... The post Deals and M&As thi...
Deals this week: Celsius Therapeutics, Xenikos, Nohla Therapeutics
Celsius Therapeutics has raised $65m in a series A financing round led by Third Rock Ventures with participation from Google Ventures,...Read More... The post Deals this week: Celsius Therapeutics, X...
Alexion to Acquire Wilson Therapeutics and its Rare Liver Disorder Drug
NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Wilson Therapeutics AB (publ) announced today that Alexion has made a recommended public cash offer to the ...
Drugs and Medications
Aldex [Pernix Therapeutics, LLC]
ALDEX GS™ Tablets
Aldex [Pernix Therapeutics, LLC]
ALDEX GS DMTablets
Pro-den rx [Zila Therapeutics, Inc.]
Pro-Den Rx
Pro-den rx [Zila Therapeutics, Inc.]
Pro-Den Rx
Pro-den rx [Zila Therapeutics, Inc.]
Pro-Den Rx
PubMed Articles
RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.
RNA-targeted therapeutics for lipid disorders.
To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.
Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...
Clinical Trials
Impact of Ibis on Patients With Advanced COPD
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...
Companies
Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...
Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...
Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...
Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics⢠solutions to benefit people with unmet medical needs through cognitive and neurobehavi...
More Information about "Bioharmony Therapeutics, Inc." on BioPortfolio
We have published hundreds of Bioharmony Therapeutics, Inc. news stories on BioPortfolio along with dozens of Bioharmony Therapeutics, Inc. Clinical Trials and PubMed Articles about Bioharmony Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioharmony Therapeutics, Inc. Companies in our database. You can also find out about relevant Bioharmony Therapeutics, Inc. Drugs and Medications on this site too.
